Ossur Hf : Interim report Q1 2018
Announcement no. 31/2018 Interim report Q1 2018 25 April 2018 Highlights Q1 2018 · Sales amounted to USD 142 million, corresponding to 8% USD growth and 1% organic growth. · The prosthetics segment grew 4% while sales of B&S products declined 1%. · Gross profit amounted to USD 88 million or 62% of sales, the same as in the comparable quarter last year. · EBITDA amounted to USD 20 million or 14% of sales, compared to 16% in Q1 2017. Currency movements impacted the EBITDA margin negatively by approx. 50 basis points. · Net profit amounted to USD 10 million or 7% of sales.